Quest Diagnostics Incorporated (DGX) Financial Statements (2026 and earlier)

Company Profile

Business Address 500 PLAZA DRIVE
SECAUCUS, NJ 07094
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 8071 - Medical Laboratories (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4205496863158721,158
Cash and cash equivalent4205496863158721,158
Receivables1,4081,3041,2101,1951,4381,520
Inventory, net of allowances, customer advances and progress billings189188190192208223
Inventory189188190192208223
Prepaid expense 32474826362
Other undisclosed current assets329304238170187155
Total current assets:2,3782,3922,3721,8982,7413,058
Noncurrent Assets
Operating lease, right-of-use asset657651602585597604
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization2,2032,1131,8161,7661,7071,627
Long-term investments and receivables136123135132141521
Long-term investments136123135132141521
Intangible asset, including goodwill, after accumulated amortization10,58110,6198,8998,3128,2628,040
Goodwill8,9458,8567,7337,2207,0956,873
Intangible asset, excluding goodwill, after accumulated amortization1,6361,7631,1661,0921,1671,167
Other noncurrent assets270255198144163176
Total noncurrent assets:13,84713,76111,65010,93910,87010,968
TOTAL ASSETS:16,22516,15314,02212,83713,61114,026
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,6001,3941,3591,3961,6001,633
Interest and dividends payable✕✕✕✕✕100102
Taxes payable✕✕✕✕✕1043
Employee-related liabilities✕✕✕✕✕518502
Accounts payable 307287378324357446
Accrued liabilities 338306287392460356
Other undisclosed accounts payable and accrued liabilities955801694680155184
Debt507603304444
Other undisclosed current liabilities171172152151149139
Total current liabilities:2,2782,1691,8151,5511,7531,776
Noncurrent Liabilities
Long-term debt and lease obligation, including:5,1675,6154,4103,9784,0104,013
Long-term debt, excluding current maturities 5,1675,6154,4103,9784,0104,013
Finance lease, liability 1816673225
Other undisclosed long-term debt and lease obligation(18)(16)(6)(7)(526)(524)
Liabilities, other than long-term debt1,4941,4731,3791,301792847
Other liabilities957938876812792847
Operating lease, liability537535503489494499
Other undisclosed noncurrent liabilities     494499
Total noncurrent liabilities:6,6617,0885,7895,2795,2965,359
Total liabilities:8,9399,2577,6046,8307,0497,135
Temporary equity, including noncontrolling interest808376777982
Equity
Equity, attributable to parent7,1706,7786,3075,8936,4446,759
Common stock222222
Treasury stock, value(5,180)(4,857)(4,826)(4,673)(3,453)(5,366)
Additional paid in capital2,3812,3612,3202,2952,2602,841
Accumulated other comprehensive loss(27)(88)(14)(21)(14)(21)
Retained earnings9,9949,3608,8258,2907,6499,303
Equity, attributable to noncontrolling interest363535373950
Total equity:7,2066,8136,3425,9306,4836,809
TOTAL LIABILITIES AND EQUITY:16,22516,15314,02212,83713,61114,026

Income Statement (P&L) ($ in millions)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues11,0359,8729,2529,88310,7889,437
Cost of revenue(7,370)(6,628)(6,199)(6,450)(6,579)(5,804)
Gross profit:3,6653,2443,0533,4334,2093,633
Operating expenses(2,121)(1,897)(1,750)(1,994)(1,830)(1,653)
Other operating income (expense), net12(1)(41)(11)2(9)
Operating income:1,5561,3461,2621,4282,3811,971
Nonoperating income (expense)(238)(171)(132)(193)218(87)
Other nonoperating income (expense)263020(55)36976
Interest and debt expense (2)(1)(163)(148)(152)(166)
Other undisclosed income from continuing operations before equity method investments, income taxes 21163148152166
Income from continuing operations before equity method investments, income taxes:1,3181,1751,1301,2352,5991,884
Income from equity method investments421926447875
Income from continuing operations before income taxes:1,3601,1941,1561,2792,6771,959
Income tax expense(314)(273)(248)(264)(597)(460)
Income from continuing operations:1,0469219081,0152,0801,499
Income before gain (loss) on sale of properties:✕✕✕✕✕2,0801,499
Net income:1,0469219081,0152,0801,499
Net loss attributable to noncontrolling interest(54)(50)(54)(69)(85)(68)
Net income available to common stockholders, diluted:9928718549461,9951,431

Comprehensive Income ($ in millions)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net income:1,0469219081,0152,0801,499
Other comprehensive income (loss)61(74)7(7)718
Comprehensive income:1,1078479151,0082,0871,517
Comprehensive loss, net of tax, attributable to noncontrolling interest(54)(50)(54)(69)(85)(68)
Comprehensive income, net of tax, attributable to parent:1,0537978619392,0021,449

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: